Ming-Hsi Huang

Title: The Innovations of Ming-Hsi Huang

Introduction

Ming-Hsi Huang is a notable inventor based in Miaoli County, Taiwan. He has made significant contributions to the field of immunology through his innovative patents. With a total of 4 patents, his work focuses on enhancing vaccine efficacy and safety.

Latest Patents

One of his latest patents is titled "Nanoemulsion adjuvant for nasal mucosa and preparation method thereof." This invention provides a nanoemulsion adjuvant composed of a continuous aqueous phase containing HO molecules, an oil phase material with fats and oils, and an emulsion system that stabilizes the interface between these phases. Notably, the emulsion system does not contain an ionic emulsifier, and the particle size of the emulsion ranges from 20 to 200 nanometers. This innovation aims to prevent the toxicity associated with ionic emulsifiers, thereby offering a vaccine preparation that can elicit a robust immune response. Another significant patent is the "Immunogenic peptide containing a B cell epitope of tumor-associated antigen L6." This patent describes an immunogenic peptide with the sequence CLDSLGQWN (SEQ ID NO:2) and outlines a method for using this peptide in cancer treatment.

Career Highlights

Ming-Hsi Huang has worked with esteemed organizations such as the National Health Research Institutes and Academia Sinica. His experience in these institutions has allowed him to contribute to groundbreaking research and development in the field of health sciences.

Collaborations

He has collaborated with notable colleagues, including Chih-Hsiang Leng and Shih-Jen Liu, further enhancing the impact of his work in the scientific community.

Conclusion

Ming-Hsi Huang's innovative contributions to immunology through his patents demonstrate his commitment to advancing medical science. His work not only addresses critical health challenges but also paves the way for future research and development in vaccine technology.